Bispecific Antibodies and Advances in Non–Gene Therapy Options in Hemophilia

por Shima, Midori
Publicado 2020

Monoclonal antibody-based therapies

por Shima, Midori
Publicado 2018

An ecological association of number of civil servants and physicians with prefectural-level rapid COVID-19 vaccination of older people in Japan

por Tomioka, Kimiko, Shima, Midori, Saeki, Keigo
Publicado 2023

Association between heaviness of cigarette smoking and serious psychological distress is stronger in women than in men: a nationally representative cross-sectional survey in Japan

por Tomioka, Kimiko, Shima, Midori, Saeki, Keigo
Publicado 2021

Occupational status and self-reported low back pain by gender: a nation-wide cross-sectional study among the general population in Japan

por Tomioka, Kimiko, Shima, Midori, Saeki, Keigo
Publicado 2021

Number of public health nurses and COVID-19 incidence rate by variant type: an ecological study of 47 prefectures in Japan

por Tomioka, Kimiko, Shima, Midori, Saeki, Keigo
Publicado 2022

Age differences in the association of physical leisure activities with incident disability among community-dwelling older adults

por Tomioka, Kimiko, Shima, Midori, Saeki, Keigo
Publicado 2022

Fraction and Number of Unemployed Associated with Self-Reported Low Back Pain: A Nation-Wide Cross-Sectional Study in Japan

por Tomioka, Kimiko, Kitahara, Teruyo, Shima, Midori, Saeki, Keigo
Publicado 2021

Anti-Factor V inhibitor in patients with autoimmune diseases: case report and literature review

por Imashuku, Shinsaku, Hasegawa, Takeshi, Kubo, Kagekatsu, Nakato, Masaki, Shima, Midori
Publicado 2011

Clinical utility and impact of the use of the chromogenic vs one‐stage factor activity assays in haemophilia A and B

por Marlar, Richard A., Strandberg, Karin, Shima, Midori, Adcock, Dorothy M.
Publicado 2019

Study protocol for assessment of the coagulation potential of concomitantly used factor VIII concentrates in patients with haemophilia A with emicizumab prophylaxis (CAGUYAMA Study...

por Takeyama, Masahiro, Ozu, Naoki, Kasama, Shu, Kasahara, Masato, Matsumoto, Masanori, Shima, Midori, Nogami, Keiji
Publicado 2023

Generation of functional liver sinusoidal endothelial-like cells from human bone marrow-derived mesenchymal stem cells

por Mitani, Seiji, Onodera, Yu, Hosoda, Chihiro, Takabayashi, Yoko, Sakata, Asuka, Shima, Midori, Tatsumi, Kohei
Publicado 2023

Characterization of anti-factor VIII antibody in a patient with acquired hemophilia A

por Oh, Jisu, Lim, Yeongmin, Jang, Moon Ju, Huh, Ji Young, Shima, Midori, Oh, Doyeun
Publicado 2013

Repression of Factor VIII Inhibitor Development with Apoptotic Factor VIII-expressing Embryonic Stem Cells

por Sakurai, Yoshihiko, Kasuda, Shogo, Tatsumi, Kohei, Takeda, Tomohiro, Kato, Junko, Kubo, Atsushi, Shima, Midori
Publicado 2013

A Novel Cell-Sheet Technology That Achieves Durable Factor VIII Delivery in a Mouse Model of Hemophilia A

por Tatsumi, Kohei, Sugimoto, Mitsuhiko, Lillicrap, David, Shima, Midori, Ohashi, Kazuo, Okano, Teruo, Matsui, Hideto
Publicado 2013

Membranous nephropathy with acquired factor V inhibitor: a case report

por Kitamura, Shinji, Misawa, Mahito, Namba, Sayaka, Tsuji, Kenji, Torigoe, Rikako, Shima, Midori, Makino, Hirofumi
Publicado 2013

Thyroid function in patients with selenium deficiency exhibits high free T4 to T3 ratio

por Kobayashi, Ryohei, Hasegawa, Mari, Kawaguchi, Chiharu, Ishikawa, Naoko, Tomiwa, Kiyotaka, Shima, Midori, Nogami, Keiji
Publicado 2021

Lupus anticoagulant hypoprothrombinemia syndrome in Bence-Jones protein κ-type multiple myeloma patient with phosphatidylserine-dependent antiprothrombin antibody

por Hara, Yoshitaka, Makita, Masanori, Ishikawa, Tatsunori, Saeki, Kyosuke, Yamamoto, Kazuhiko, Imajo, Kenji, Shima, Midori, Ieko, Masahiro
Publicado 2012

Delivery of Full-Length Factor VIII Using a piggyBac Transposon Vector to Correct a Mouse Model of Hemophilia A

por Matsui, Hideto, Fujimoto, Naoko, Sasakawa, Noriko, Ohinata, Yasuhide, Shima, Midori, Yamanaka, Shinya, Sugimoto, Mitsuhiko, Hotta, Akitsu
Publicado 2014

A multicentre, open‐label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors

por Shima, Midori, Nogami, Keiji, Nagami, Sayaka, Yoshida, Seitaro, Yoneyama, Koichiro, Ishiguro, Akira, Suzuki, Takashi, Taki, Masashi
Publicado 2019